<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Holcomb JB</submitter><funding>NCATS NIH HHS</funding><funding>NCRR NIH HHS</funding><pagination>127-36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3740072</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>148(2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma:red blood cell (RBC) and platelet:RBC ratios.&lt;h4>Design&lt;/h4>Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using time-dependent proportional hazards models.&lt;h4>Setting&lt;/h4>Ten US level I trauma centers.&lt;h4>Patients&lt;/h4>Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n = 1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n = 905, the analysis group).&lt;h4>Main outcome measure&lt;/h4>In-hospital mortality.&lt;h4>Results&lt;/h4>Plasma:RBC and p</pubmed_abstract><journal>JAMA surgery</journal><pubmed_title>The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.</pubmed_title><pmcid>PMC3740072</pmcid><funding_grant_id>UL1 RR024148</funding_grant_id><funding_grant_id>UL1 TR000005</funding_grant_id><pubmed_authors>Holcomb JB</pubmed_authors><pubmed_authors>Muskat P</pubmed_authors><pubmed_authors>Underwood SJ</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Johannigman JA</pubmed_authors><pubmed_authors>Robinson BR</pubmed_authors><pubmed_authors>Rahbar MH</pubmed_authors><pubmed_authors>Cotton BA</pubmed_authors><pubmed_authors>Alarcon LH</pubmed_authors><pubmed_authors>Carroll E</pubmed_authors><pubmed_authors>Coates EC</pubmed_authors><pubmed_authors>Scerbo M</pubmed_authors><pubmed_authors>Sambucini RL</pubmed_authors><pubmed_authors>Elopre M</pubmed_authors><pubmed_authors>White CE</pubmed_authors><pubmed_authors>Zolin SJ</pubmed_authors><pubmed_authors>Knudson M</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Podbielski J</pubmed_authors><pubmed_authors>Gildea M</pubmed_authors><pubmed_authors>Caga-Anan Z</pubmed_authors><pubmed_authors>Shnol HL</pubmed_authors><pubmed_authors>Branson R</pubmed_authors><pubmed_authors>McCarthy J</pubmed_authors><pubmed_authors>Reynolds RJ</pubmed_authors><pubmed_authors>Nelson M</pubmed_authors><pubmed_authors>Brasel KJ</pubmed_authors><pubmed_authors>Bulger EM</pubmed_authors><pubmed_authors>Hatch QM</pubmed_authors><pubmed_authors>Jonas R</pubmed_authors><pubmed_authors>Matijevic N</pubmed_authors><pubmed_authors>Curren J</pubmed_authors><pubmed_authors>Stull SD</pubmed_authors><pubmed_authors>Wade CE</pubmed_authors><pubmed_authors>PROMMTT Study Group</pubmed_authors><pubmed_authors>Benjamin-Garner R</pubmed_authors><pubmed_authors>Minei JP</pubmed_authors><pubmed_authors>Dahl C</pubmed_authors><pubmed_authors>Klotz P</pubmed_authors><pubmed_authors>Gomaa D</pubmed_authors><pubmed_authors>Early BJ</pubmed_authors><pubmed_authors>DeRosa M</pubmed_authors><pubmed_authors>Warner KJ</pubmed_authors><pubmed_authors>Myers JG</pubmed_authors><pubmed_authors>Call MS</pubmed_authors><pubmed_authors>Cohen MJ</pubmed_authors><pubmed_authors>Sears SB</pubmed_authors><pubmed_authors>Franzen KL</pubmed_authors><pubmed_authors>Phelan HA</pubmed_authors><pubmed_authors>Bai Y</pubmed_authors><pubmed_authors>Walsh P</pubmed_authors><pubmed_authors>Peitzman AB</pubmed_authors><pubmed_authors>Duran SJ</pubmed_authors><pubmed_authors>Kampmeyer M</pubmed_authors><pubmed_authors>Fox EE</pubmed_authors><pubmed_authors>Stewart RM</pubmed_authors><pubmed_authors>del Junco DJ</pubmed_authors><pubmed_authors>Schreiber MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.</name><description>&lt;h4>Objective&lt;/h4>To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma:red blood cell (RBC) and platelet:RBC ratios.&lt;h4>Design&lt;/h4>Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using time-dependent proportional hazards models.&lt;h4>Setting&lt;/h4>Ten US level I trauma centers.&lt;h4>Patients&lt;/h4>Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n = 1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n = 905, the analysis group).&lt;h4>Main outcome measure&lt;/h4>In-hospital mortality.&lt;h4>Results&lt;/h4>Plasma:RBC and p</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Feb</publication><modification>2026-04-16T23:21:17.548Z</modification><creation>2026-04-07T14:22:57.84Z</creation></dates><accession>S-EPMC3740072</accession><cross_references><pubmed>23560283</pubmed><doi>10.1001/2013.jamasurg.387</doi></cross_references></HashMap>